ALPS Advisors’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-278,504
| Closed | -$1M | – | 875 |
|
|
2019
Q3 | $1M | Sell |
278,504
-11,856
| -4% | -$42.7K | 0.01% | 310 |
|
|
2019
Q2 | $778K | Sell |
290,360
-44,450
| -13% | -$119K | 0.01% | 388 |
|
|
2019
Q1 | $991K | Buy |
334,810
+14,460
| +5% | +$42.8K | 0.01% | 329 |
|
|
2018
Q4 | $509K | Buy |
320,350
+75,105
| +31% | +$119K | ﹤0.01% | 475 |
|
|
2018
Q3 | $903K | Buy |
245,245
+44,480
| +22% | +$164K | 0.01% | 429 |
|
|
2018
Q2 | $568K | Buy |
200,765
+15,797
| +9% | +$44.7K | ﹤0.01% | 509 |
|
|
2018
Q1 | $686K | Buy |
184,968
+32,205
| +21% | +$119K | 0.01% | 388 |
|
|
2017
Q4 | $440K | Buy |
152,763
+18,074
| +13% | +$52.1K | ﹤0.01% | 658 |
|
|
2017
Q3 | $605K | Buy |
134,689
+11,277
| +9% | +$50.7K | ﹤0.01% | 340 |
|
|
2017
Q2 | $566K | Buy |
123,412
+5,824
| +5% | +$26.7K | ﹤0.01% | 393 |
|
|
2017
Q1 | $495K | Sell |
117,588
-13,763
| -10% | -$57.9K | ﹤0.01% | 437 |
|
|
2016
Q4 | $542K | Sell |
131,351
-42,895
| -25% | -$177K | ﹤0.01% | 336 |
|
|
2016
Q3 | $1.41M | Sell |
174,246
-17,707
| -9% | -$143K | 0.01% | 205 |
|
|
2016
Q2 | $1.5M | Buy |
191,953
+38,285
| +25% | +$299K | 0.01% | 189 |
|
|
2016
Q1 | $1.19M | Sell |
153,668
-26,209
| -15% | -$202K | 0.01% | 178 |
|
|
2015
Q4 | $1.94M | Sell |
179,877
-4,131
| -2% | -$44.6K | 0.02% | 181 |
|
|
2015
Q3 | $12.7K | Buy |
184,008
+67,347
| +58% | +$4.65K | 0.01% | 202 |
|
|
2015
Q2 | $1.03M | Buy |
116,661
+60,811
| +109% | +$539K | 0.01% | 212 |
|
|
2015
Q1 | $551K | Buy |
+55,850
| New | +$551K | ﹤0.01% | 287 |
|